NCT00562380View on ClinicalTrials.gov

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

June 30, 2010

Conditions
LymphomaProstate CancerSarcomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

ganitumab

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

PROCEDURE

biopsy

Trial Locations (1)

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Amgen

INDUSTRY